NAD+ Nasal Spray: Can It Absorb Through the Nose?

NAD+ nasal sprays are sold as the convenient, needle-free way to "boost your NAD+" — spritz it up your nose, skip the IV drip and the injection, and let the molecule absorb through the nasal lining. The pitch leans on a kernel of real science: the nose genuinely is a delivery route some drugs use, and a famous set of animal studies did put NAD+ up rodents' noses. But the leap from those facts to "a nasal spray raises your NAD+ and delivers energy, focus, or longevity benefits" is almost entirely unsupported.

We'll be blunt up front, because this is a topic where the marketing badly outruns the data: there is no published human study showing that an NAD+ nasal spray is absorbed, raises blood or brain NAD+, or produces any clinical benefit. The intranasal NAD+ evidence that exists is preclinical — rats and mice with acute brain injury — and even there it was tested as a neuroprotective rescue, not as a wellness booster. This page lays out what is actually known, where the real science stops, and why the absorption claims deserve heavy skepticism. (We sell editorial honesty here, not nasal sprays — and yes, that includes scrutinizing our own featured brand's nasal product.)

The honest headline: NAD+ nasal spray is essentially unstudied in humans

Search the human clinical-trial literature for intranasal NAD+ and you come up empty. The serious human evidence for raising NAD+ at all is built on oral precursors — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — which reliably raise blood NAD+ but deliver only modest, mixed, or null downstream benefits ⁶⁷. There is no equivalent body of work for nasal NAD+. No pharmacokinetic study has measured what happens to blood or brain NAD+ after a human uses an NAD+ nasal spray. No randomized trial has tested whether it does anything you'd feel.

That single fact reframes the whole category. When a product claims a nasal spray "delivers NAD+ directly," ask the only question that matters: delivers it where, and proven how? For nasal NAD+, the honest answer is "unknown, and never measured in people." We say the same thing about every non-oral route in our NAD+ therapy evidence pillar — the IV, injection, and nasal routes share one defining feature, which is the absence of controlled human outcome data.

What NAD+ actually is — and why the nose is a hard delivery problem

NAD+ (nicotinamide adenine dinucleotide) is a large, charged coenzyme central to cellular energy metabolism and DNA repair, whose tissue levels tend to fall with age — the entire rationale for trying to "restore" it ¹. That same chemistry is exactly what makes any membrane it's meant to cross — gut, skin, or nasal lining — a genuine obstacle. NAD+ is water-soluble, unstable, and too big and polar to slip across a biological barrier efficiently as an intact molecule. (The same size-and-charge problem is even starker for the skin barrier, which is why we're equally skeptical of transdermal NAD+ patches.)

The nasal route does not magically erase that problem. Intranasal delivery is a real, actively researched field, but reviews of it are clear that it works best for small, lipophilic (fat-loving) molecules; large, water-soluble biomacromolecules cross the nasal lining poorly and usually need penetration enhancers, special formulations, or enzyme-inhibiting tricks to get meaningful uptake ⁹. Even intranasal peptides — a class engineered and studied specifically for nose-to-brain delivery — face low bioavailability and rapid clearance as the central challenges of the approach ¹⁰. NAD+ is larger and more charged than many of those peptides. Nothing about its chemistry makes it a good nasal candidate; if anything, it's a hard one.

The real intranasal NAD+ studies — and what they actually tested

So where does the "NAD+ goes up your nose" idea come from? From a small set of legitimate animal experiments, which marketing then quietly rounds up into a human benefit claim.

In a 2007 rat study, intranasal NAD+ given after an induced stroke (transient focal ischemia) profoundly reduced brain injury — cutting the size of the damaged area — compared with untreated animals ². A 2012 mouse study similarly found that intranasal NAD+ prevented neuron death after traumatic brain injury ³. Related work showed NAD+ administration reduced ischemic brain damage in a mouse stroke model ⁴. These are real, peer-reviewed findings, and they fit a coherent mechanism: NAD+ and its balance with NADH are deeply involved in how stressed neurons live or die ⁵.

But look hard at what those studies were and were not:

• •They were done in rodents, not people.
• •They modeled acute catastrophic brain injury — stroke and head trauma — not the everyday "low energy" or "brain fog" a nasal spray is marketed for.
• •They measured tissue damage in the brain, not blood NAD+ levels, not "energy," not longevity, and not anything a healthy consumer would experience.
• •They were rescue experiments: flood an injured brain with NAD+ to limit death. That is a fundamentally different question from "does daily nasal NAD+ make a healthy adult function better?"

In other words, the strongest intranasal-NAD+ science in existence is preclinical neuroprotection research, and it does not establish that a nasal spray raises a healthy person's NAD+ or improves how they feel. Treat those animal results as an interesting hypothesis about brain injury — not as evidence for the consumer product.

"Nose-to-brain" is a real concept — but it's mostly an aspiration, not a delivery guarantee

The most sophisticated version of the nasal pitch invokes the nose-to-brain pathway: the idea that molecules can travel along the olfactory and trigeminal nerves from the nasal cavity directly into the brain, bypassing the blood–brain barrier. This pathway is genuinely real and is the subject of serious pharmaceutical research, including efforts to deliver Alzheimer's drugs this way ¹¹.

But the same research literature is candid that nose-to-brain delivery remains difficult and largely unproven for large molecules — clinical translation has been slow, only a fraction of any dose reaches the brain, and getting reproducible, meaningful CNS delivery is exactly the unsolved problem the field is working on ¹¹¹⁰. "There is a pathway in principle" is not the same as "this nasal spray uses it effectively." For NAD+ specifically, no human study has demonstrated nose-to-brain delivery at all. Invoking the pathway to sell a supplement borrows the credibility of pharmaceutical research without any of the product-specific evidence that research demands.

What actually has human evidence for raising NAD+ (it isn't a spray)

Strip away the delivery theater and the picture is consistent across our coverage. The molecules with real human data for raising blood NAD+ are the plain oral precursors:

• •Nicotinamide riboside (NR) is established as uniquely and orally bioavailable in mice and humans, raising blood NAD+ in a controlled way ⁷.
• •NMN raises blood NAD+ too, largely via an indirect breakdown-and-rebuild route through the gut and liver rather than intact absorption ⁶.

And even for those well-studied precursors, reliably raising the NAD+ biomarker has repeatedly failed to translate into proven benefits on energy, cognition, or metabolism — a pooled analysis found the human metabolic benefits limited and inconsistent despite raised NAD+ ⁸. The one human study of putting NAD+ directly into the body — a 6-hour IV infusion — measured biochemistry, not outcomes, and it's the closest thing to direct human NAD+ data that exists ¹². There is nothing remotely comparable for the nasal route. We walk through that whole route-by-route picture in our NAD+ injections evidence guide, our NAD+ IV therapy evidence and cost guide, and our look at whether liposomal NAD+ really absorbs orally — and the nasal route sits at the least-evidenced end of all of them.

So can NAD+ absorb through the nose? An honest verdict

Putting it together:

1. 1.NAD+ is a large, charged, unstable molecule — chemically a poor candidate for crossing the nasal lining intact, exactly as it's a poor candidate for crossing the gut ¹⁹.
2. 2.The nasal and nose-to-brain routes are real but work best for small lipophilic drugs, and remain a hard, partly unsolved problem even for purpose-built peptides and CNS drugs ⁹¹⁰¹¹.
3. 3.The only intranasal NAD+ evidence is animal neuroprotection research in acute brain injury — not human data, not healthy-person data, and not a measure of blood NAD+, energy, or longevity ²³⁴⁵.
4. 4.No human study has shown an NAD+ nasal spray is absorbed, raises NAD+, or does anything you'd notice.

The honest verdict: we don't know that NAD+ meaningfully absorbs through the nose in humans, and there's good chemical reason to doubt it does so efficiently. That doesn't make a nasal spray definitively useless or harmful — it means the central absorption claim is unproven, extrapolated from rodent brain-injury studies that were never designed to support it. If your goal is to raise NAD+, the evidence points to inexpensive, well-characterized oral precursors, and to keeping expectations modest about what higher NAD+ actually does. To compare products, forms, and providers on dose, route, and third-party testing — and to see where the nasal option honestly ranks — see our NAD+ rankings hub.

This is consumer education, not medical advice. If you have a medical condition, are pregnant, or take other medications, talk to a clinician before starting any NAD+ product.